OLIX PHARMACEUTICALS, INC. financial statements, including revenue, expenses, profit, and loss

The total revenue of 226950 for the last quarter is 263.81 M KRW, and it's 94.26% lower compared to the previous quarter. The net income of Q3 24 is -10.51 B KRW.